|
|
Volumn 61, Issue 21 Suppl 5, 2004, Pages
|
|
Overview of bevacizumab: a new cancer therapeutic strategy targeting vascular endothelial growth factor.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
VASCULOTROPIN A;
CLINICAL TRIAL;
DRUG ANTAGONISM;
HUMAN;
NEOPLASM;
REVIEW;
ANTIBODIES, MONOCLONAL;
CLINICAL TRIALS;
HUMANS;
NEOPLASMS;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
MLCS;
MLOWN;
|
|
EID: 16644377775
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/61.suppl_5.s21 Document Type: Review |
|
Times cited : (66)
|
|
References (27)
|
